Nesvacumab
Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. , the drug was in Phase II clinical trials for the treatment of diabetic macular edema. This drug is being developed by Regeneron Pharmaceuticals.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1320233791 under CC BY-SA 4.0; modifications have been made.